New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem
Erik Kobayashi-Solomon and Erin Swanson hash out how niche player Chattem has maintained its impressive operating margins despite competition from giants like Proctor and Gamble.
We believe breakups could unlock value for big pharma shareholders.
A large generics business and niche pipeline keep Novartis ahead of the curve.